MWG Caph
WASHINGTON, DCfiles as MWG Caph Ltd
$72m in 3 US stocks at the end of 31 December 2025. The top 10 are 100.0% of the money.
Value
$72m
Stocks
3
Top 10 share
100.0%
Turnover
n/a
What changed this quarter
This is the first quarter we have for this fund, so we can't show changes yet.
Holdings
- Beam TherapeuticsBEAM
- Share
- 48.5%
- Value
- $35m
- Shares
- 1,266,934
- Lyell ImmunopharmaLYEL
- Share
- 42.9%
- Value
- $31m
- Shares
- 1,008,116
- Prime MedicinePRME
- Share
- 8.6%
- Value
- $6m
- Shares
- 1,792,210
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Beam TherapeuticsBEAM | 48.5% | $35m | 1,266,934 | |
| Lyell ImmunopharmaLYEL | 42.9% | $31m | 1,008,116 | |
| Prime MedicinePRME | 8.6% | $6m | 1,792,210 |
Over time and by industry
Value over time
Dec '25
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.